TrialThe New England journal of medicine2022
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
Myron J Levin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
405 papers cite itlatest 60 shown
this paperpooled ittrialcites it